BURLINGTON -
The addition of Toxikon to Labcorp Drug Development bolsters
The definitive agreement for the transaction was announced on
About
Contact:
Tel: 336-436-8263
Email: Media@Labcorp.com
(C) 2021 Electronic News Publishing, source
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
207.9 USD | -0.01% | +3.99% | -8.51% |
BURLINGTON -
The addition of Toxikon to Labcorp Drug Development bolsters
The definitive agreement for the transaction was announced on
About
Contact:
Tel: 336-436-8263
Email: Media@Labcorp.com
(C) 2021 Electronic News Publishing, source
1st Jan change | Capi. | |
---|---|---|
-8.51% | 17.5B | |
-14.17% | 86.34B | |
+17.86% | 84.49B | |
+10.92% | 29.68B | |
-2.67% | 16.67B | |
-0.24% | 15.18B | |
-3.63% | 12.71B | |
+2.63% | 12.53B | |
-30.53% | 11.89B | |
+26.71% | 11.74B |